// App-Quantinova.ai

B-184 : Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients

Researchers

Presenter

  • Y. Kang

Principal Investigators

  • V. M. Aquino

  • A. Y. Koh

  • D. Wetzel

  • P. K. Sue

Medical Centers

  • Pediatrics, UT Southwestern Medical Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Musculoskeletal

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Tedizolid phosphate

  • Biaxin

  • Ciprofloxacin

  • Moxifloxacin

  • Minocycline

  • Doxycycline

  • Cefoxitin

  • Linezolid

  • Amikacin

  • imipenem

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved